BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12360565)

  • 1. Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.
    Zijlmans J; Booij J; Valk J; Lees A; Horstink M
    Mov Disord; 2002 Sep; 17(5):1086-8. PubMed ID: 12360565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posttraumatic intention tremor. Report of a case with a lesion in the mesencephalic area].
    Pascual-Castroviejo I; Pascual Pascual SI; Viaño J; Martínez V
    Neurologia; 2000 Mar; 15(3):128-31. PubMed ID: 10846874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of presynaptic nigrostriatal pathway by 123-I-FD-CIT-SPECT (DatSCAN SPECT) in primary orthostatic tremor].
    Vaamonde J; García A; Flores JM; Ibáñez R; Gargallo L
    Neurologia; 2006; 21(1):37-9. PubMed ID: 16525925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
    Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
    Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease.
    Reck C; Florin E; Wojtecki L; Krause H; Groiss S; Voges J; Maarouf M; Sturm V; Schnitzler A; Timmermann L
    Eur J Neurosci; 2009 Feb; 29(3):599-612. PubMed ID: 19187268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomelic parkinsonian tremor caused by contralateral substantia nigra stroke.
    Gonzalez-Alegre P
    Parkinsonism Relat Disord; 2007 Apr; 13(3):182-4. PubMed ID: 16731026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism.
    Franquet E; Salvadó-Figueres M; Lorenzo-Bosquet C; Cuberas-Borrós G; Rovira A; Castell-Conesa J; Hernandez-Vara J
    Mov Disord; 2012 Sep; 27(10):1220-1. PubMed ID: 22976778
    [No Abstract]   [Full Text] [Related]  

  • 11. [An adult case of probable Bassen-Kornzweig syndrome, presenting resting tremor].
    Soejima N; Ohyagi Y; Kikuchi H; Murai H; Shigeto H; Kira J
    Rinsho Shinkeigaku; 2006 Oct; 46(10):702-6. PubMed ID: 17323779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal dopaminergic function in subjects with isolated action tremor.
    Coria F; Gimenez-Garcia M; Samaranch L; Mora FJ; Sampol-Bas C; Pastor P
    Parkinsonism Relat Disord; 2012 Jan; 18(1):49-53. PubMed ID: 21917500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary parkinsonism following midbrain hemorrhage].
    Inoue H; Udaka F; Takahashi M; Nishinaka K; Kameyama M
    Rinsho Shinkeigaku; 1997 Mar; 37(3):266-9. PubMed ID: 9217431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Rubral" tremor induced by a neuroleptic drug.
    Friedman JH
    Mov Disord; 1992; 7(3):281-2. PubMed ID: 1620147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.
    Marek K; Jennings D; Seibyl J
    Ann Neurol; 2003; 53 Suppl 3():S160-6; discussion S166-9. PubMed ID: 12666107
    [No Abstract]   [Full Text] [Related]  

  • 17. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
    Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
    Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Parkinson's disease revealed by a pure head resting tremor.
    Gan J; Xie-Brustolin J; Gervais-Bernard H; Vallet AE; Broussolle E; Thobois S
    J Neurol Sci; 2009 Apr; 279(1-2):121-3. PubMed ID: 19176228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.